Diffuse Neonatal Hemangiomatosis with Unilateral Cranial Nerve Palsy Improved by Propranolol.
- Author:
Sung Woo KIM
1
;
Ji Kyoung PARK
;
Ga Won JEON
;
Jong Beom SIN
Author Information
- Publication Type:Case Report
- Keywords: Abducens nerve palsy; Facial palsy; Hemangioma; Propranolol
- MeSH: Abducens Nerve Diseases; Adrenal Cortex Hormones; Arm; Brain; Buttocks; Capillaries; Central Nervous System; Cerebellum; Cranial Nerve Diseases*; Cranial Nerves*; Facial Paralysis; Heart Failure; Hemangioma; Hemangioma, Cavernous; Hemorrhage; Humans; Infant; Infant, Newborn; Kidney; Lip; Liver; Lung; Mortality; Neck; Pons; Prednisolone; Propranolol*; Shoulder; Skin
- From:Neonatal Medicine 2016;23(2):116-120
- CountryRepublic of Korea
- Language:English
- Abstract: Diffuse neonatal hemangiomatosis (DNH) is characterized by multiple capillary or cavernous hemangiomas on the skin and internal organs occurring during the neonatal period. It is a life-threatening condition due to high-output heart failure with a mortality rate of 60-85% without proper treatment. The areas that are most commonly involved include the skin (100%), liver (64-100%), and central nervous system (52%). Corticosteroids are the drugs of choice as an initial treatment and have a response rate of 30-60%. We present here a case of a newborn baby with multiple hemangiomas on her skin (scalp, lips, neck, back, shoulder, arm, buttock, and leg), brain (right cerebellum, pons, and medulla oblongata), lungs, liver, kidney, and bones. She suffered from 6th, 7th, 9th, 10th, and 12th cranial nerve palsy resulting from hemorrhage of the hemangiomas in the brain. The first-line treatment of prednisolone (4 mg/kg/day) was not effective and propranolol (2 mg/kg/day) was administered as a second-line treatment. After 2 weeks of treatment, the hemangiomas had decreased in size with no associated acute hemorrhage. The infant is now 10 months old and both the multiple hemangiomas and cranial nerve palsy have improved. Propranolol was effective without significant adverse effects in treating DNH resistant to corticosteroids.
